SCHEMBL7974985

SCHEMBL7974985

CC(C)Cc1cc(Cl)c(O)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
GABRA1 P14867 2/20 0.34
GABRB2 P47870 2/20 0.34
ESR1 P03372 2/20 0.34
ESR2 Q92731 1/20 0.34
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
PDE10A Q9Y233 1/20 0.33
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
KDM4E B2RXH2 1/20 0.33
USP2 O75604 1/20 0.33
TSHR P16473 1/20 0.32
LMNA P02545 1/20 0.32
AKR1C2 P52895 1/20 0.31
AKR1C1 Q04828 1/20 0.31
CXCR2 P25025 1/20 0.31
PGK1 P00558 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16502348 0.79 PGK1 (0.37) ALOX15ALOX12HPGDHSD17B10TSHR
SCHEMBL12867289 0.74 HPGD (0.32) ESR1HPGDHSD17B10TSHRPGK1
SCHEMBL20666766 0.71 LMNA (0.38) ALOX15ALOX12GABRA1ESR1ESR2
SCHEMBL6466753 0.70 NOS3 (0.40) GABRA1GABRB2ESR1ESR2HPGD
SCHEMBL13017041 0.68 SIRT6 (0.36) ESR1ESR2PDE10ANOS3NOS1
SCHEMBL12701773 0.68 NOS3 (0.41) GABRA1GABRB2ESR1ESR2PDE10A
SCHEMBL18972448 0.68 NOS3 (0.41) ESR1ESR2PDE10ANOS3NOS1
SCHEMBL17996823 0.67 ESR1 (0.68) GABRA1GABRB2ESR1ESR2HPGD
SCHEMBL17000231 0.67 NOS3 (0.36) ESR1NOS3NOS1NOS2
SCHEMBL17000224 0.67 ESR1 (0.41) ESR1ESR2HPGDPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009136350-A1 NOVEL CLASS OF SPIRO PIPERIDINES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES PFIZER INC. (US) 2009-11-12 WO disclosed